Etiology and Pathogenesis Molecular Oncology


Lancet. 2001 Jul 28;358(9278):298-300. (Laboratory Investigation)


Abstract

OLIG2 as a specific marker of oligodendroglial tumour cells

Marie Y, Sanson M, Mokhtari K, Leuraud P, Kujas M, Delattre JY, Poirier J, Zalc B, Hoang-Xuan K

OLIG2 is a recently identified transcription factor involved in the specification of cells in the oligodendroglial lineage. 

We investigated the expression of OLIG2 by in-situ hybridisation in 21 brain tumours: nine grade II and III oligodendrogliomas, three grade II oligoastrocytomas, and nine non-oligodendroglial tumours (four grade IV astrocytomas, two meningiomas, a dysembryoplastic neuroepithelial tumour, and two metastases). 
OLIG2-positive cells corresponding to neoplastic oligodendrocytes were present in all oligodendrogliomas and oligoastrocytomas. 
By contrast, OLIG2 expression was not detected in the non-oligodendroglial tumours. 
Thus, oligodendroglioma probably arise from oligodendrocyte precursor cells. 
OLIG2 should prove a useful marker for the diagnosis of oligodendroglial tumours.

PMID: 11498220 [PubMed - indexed for MEDLINE]


Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11498220


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
| BL Newsletter |
Children's Corner | E-mail Alerts | Journals | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP